My contribution to a board
I would help directors examine what a product asks a customer to decide and whether the person can understand, take time and correct a mistake before the interaction becomes consequential. My experience includes an optional extra selected by default, sessions that ended too soon for assisted users and an ambiguous household removal action. These cases provide practical questions about customer control, with the limits of the research stated alongside the improvement. They do not make me an underwriting, legal or accessibility-certification authority. I would ask how management tests the journey, how unresolved users remain visible and which professional owners approve the proposition. The board should understand the customer consequence without becoming an interface review panel. I would first need to learn the receiving company’s own service model and obligations rather than assume that an insurer application process is the right comparison for every product.
Capacity and preferences
- Time available
- 22 days per year
- Current directorships
- 0
- Sectors
- Health insurance and customer-facing financial services · Service businesses whose products ask people to make consequential choices
- Company type
- An organisation with capable product management and a chair who examines the customer consequences of design decisions
- Company stage
- Revising a customer application journey or strengthening product evidence and accessibility
The seat I am pursuing
I would consider one non-executive contribution where an experienced chair wants better scrutiny of how customers experience consequential product choices. Preparation and appointment-specific assessment come first because I have no statutory service to offer. My initial contribution could fit customer, service-risk or digital-experience discussions under established leadership, without an offer to chair a statutory committee. I would want to understand which product, insurance, legal and accessibility skills already exist and where this perspective adds value. The company should retain accountable product management and professional approvals rather than use a director as an informal design sign-off. A seat based mainly on commercial introductions would not fit. I would aim to help colleagues ask whether the customer can understand the choice, complete it at an appropriate pace and correct a mistake before the company treats the interaction as a commitment.
Judgement in practice
01The shortest path had already selected the extra
Twenty-four of thirty-six research participants treated a preselected optional addition as part of the base proposition. I would ask directors whether the organisation understands which decisions its defaults make easier and what customers believe those decisions mean. The revised explicit choice helped in a repeated exercise, but five participants still needed assistance and familiarity limited the inference. Those facts should remain visible instead of becoming a claim of universal understanding. The board’s role is to examine the customer consequence and the evidence behind release, while management designs the interaction and professionals retain pricing and insurance authority. My own approval of the earlier design matters because the preference for convenience had senior sponsorship. Useful oversight must be able to challenge that preference before a completion measure becomes the only account of success.
02Completion should include people who need longer
Twelve of thirty-two assisted-user sessions ended before the defined task was complete. The revised warning, extension and recovery experience allowed twenty-seven participants to complete in the later exercise, while five still needed an assisted route. I would ask how management accounts for those remaining needs and how security and accessibility assessments are brought together. A test result does not establish every user’s experience or certify the whole product. Directors should understand the unresolved consequence and the resources required, without prescribing a session duration from the boardroom. The useful question is whether the product account includes people whose work takes longer, rather than improving a headline by defining them out of the journey the company promises to support.
My first year on a board
I would begin by understanding the customer decisions the company regards as most consequential. Through induction agreed with the chair, I would examine one product release and one unresolved service difficulty, meeting management through established arrangements. I would ask how research participants are selected, how limitations reach the approval discussion and how customers can obtain help or correct an action after the main journey ends. Twenty-two annual days need to cover preparation, meetings, induction and exceptional demands, with employer agreement and the actual calendar settled beforehand. I would seek feedback on whether my questions clarify the customer consequence or pull the board into design management. A useful first-year contribution might make one neglected group of users or one consequential default more visible in oversight. It should serve the company’s current priorities rather than introduce a personal checklist disconnected from its service model.
Conflicts and their management
My employment provides access to product roadmaps, customer research, insurer propositions and supplier discussions. I also hold a 0.15 percent beneficial interest through the employee vehicle. The founder and fund relationships, service partners, design agencies and technology suppliers may all matter to a proposed appointment. I would disclose relevant connections before receiving confidential board material and ask the receiving company to assess eligibility and independence. I would not carry protected participant records or commercial product plans into another organisation. Recusal may address a specific supplier discussion, but repeated exclusion from the customer-product agenda could undermine the intended contribution. Employer consent and realistic capacity require practical agreement. I would decline a role that expects access to insurer partners, informal endorsement of a proposition or personal assurance that an interface satisfies professional requirements beyond the evidence and authority of the receiving company’s own process.
My independence statement
Employment, my 0.15% beneficial interest and insurer, agency and supplier relationships require assessment for the particular appointment. Product experience does not establish independence or statutory committee suitability.
Committee contribution
Chair and member readiness| Capacity | Committees |
|---|
| Ready to join | Customer product and service-risk discussions · Digital experience and accessibility oversight |
|---|
Board and committee exposure
Presented to the Board or a committee
Qazvrelthi Health Assurance
Invited product and customer-experience discussions
April 2022–present
Explains management recommendations and unresolved research findings; no statutory appointment or committee vote.
Reported to a committee
Qazvrelthi Health Assurance
Customer-product accounts through the CPO
April 2017–March 2022
Prepared research and design evidence including the withdrawn optional-extra proposal; executive reporting only.
Governance learning and readiness
IICA Independent Directors’ Databank: Not yet registered
I have not held a statutory seat. Preparation and any applicable registration remain to be completed; I do not claim a proficiency result or exemption.
- Preparing to examine customer choice through collective oversight rather than screen approval
- Learning appointment responsibilities and how commercial relationships affect a proposed contribution